The role of T, B and adherent cells in the in vitro immune response of TEPC-183-bearing mice
- PMID: 6978846
- PMCID: PMC1555334
The role of T, B and adherent cells in the in vitro immune response of TEPC-183-bearing mice
Abstract
In order to analyse the mechanism of immunosuppression of plasmacytoma-bearing mice, the role of enriched T cells, B cells, and adherent cells from the spleens of normal and TEPC-183 plasmacytoma (IgM,k) bearing mice in the primary in vitro immune response was investigated. Nylon-wool-enriched fractions of T and B cells were used in the study of T-cell-dependent immune responses to the 2-4-6-trinitrophenyl ligand. When 5 × 10-5
T and B cells derived from TEPC-183 spleens gave minimal anti-trinitrophenyl specific plaque-forming-cell responses when co-cultured with adherent cells from either normal or TEPC-183 spleens. In contrast, either T- or B-cell fractions from TEPC-183 spleens were at least partially competent when co-cultured with B or T cells from normal spleens. The data thus suggest that the suppressed state of TEPC-183 spleen cells may be due to defective T—B cell interaction. It was consistently observed that splenic adherent cells from TEPC-183-bearing mice were neither suppressed nor suppressive for the in vitro immune responses of normal splenic lymphocytes at the ratios tested. Adherent peritoneal exudate (PE) cells from either normal or TEPC-183-bearing mice were equally suppressive for the in vitro immune responses of normal splenic lymphocytes at the PE cell to lymphocyte ratios of 1:10 and 1:35. Thus, the suppressive characteristic of adherent PE cells in this system is not specific for TEPC-183 plasmacytoma in mice.
TEPC-183 spleens were found to contain 35% or more esterase-positive cells, compared with approximately 5% esterase-positive cells present in normal spleens. The possible role of esterase-positive cells, T cells, B cells, and adherent cells in the observed suppression will be discussed.
Similar articles
-
Reversal by peritoneal adherent cells of tumor cell suppression of T cell-mediated immunity.J Immunol. 1979 Aug;123(2):801-7. J Immunol. 1979. PMID: 156764 No abstract available.
-
Tumor immunity to murine plasma cell tumors. II. Essential role of T lymphocytes in immune response.Eur J Immunol. 1973 Apr;3(4):218-24. doi: 10.1002/eji.1830030408. Eur J Immunol. 1973. PMID: 4541468 No abstract available.
-
Immunosuppression in BALB/c mice bearing the plasmacytoma TEPC-183: massive increase in red pulp macrophages induced by the tumour.Immunology. 1980 Jun;40(2):223-8. Immunology. 1980. PMID: 7409859 Free PMC article.
-
Induction and immunological properties of tumor necrosis factor.J Reticuloendothel Soc. 1978 Apr;23(4):307-19. J Reticuloendothel Soc. 1978. PMID: 353278 Review. No abstract available.
-
[Neoplastic-lymphocytic hybrid cell lines].Postepy Hig Med Dosw. 1979 Sep-Oct;33(5):465-77. Postepy Hig Med Dosw. 1979. PMID: 398040 Review. Polish. No abstract available.
Cited by
-
An immunosuppressive lipoprotein fraction from TEPC-183 bearing mice.Clin Exp Immunol. 1983 Dec;54(3):801-10. Clin Exp Immunol. 1983. PMID: 6360448 Free PMC article.
-
Immunotherapy of a plasmacytoma with attenuated salmonella.Med Oncol. 1995 Jun;12(2):103-8. doi: 10.1007/BF01676710. Med Oncol. 1995. PMID: 8535659
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources